AstraZeneca
AZN
$75.03
Share price
5.38%
Change (1 day)
-0.83%
Change (1 year)
Categories
Operating Margin for AstraZeneca (AZN)
Operating Margin as of April 2024 (TTM): 5.63%
According to AstraZeneca's latest financial reports and stock price the company's current Operating Margin is 5.63%. At the end of 2022 the company had an Operating Margin of 5.64%.
Operating Margin history for AstraZeneca from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 5.64% | -896.22% |
| 2021 | -0.71% | -104.81% |
| 2020 | 14.71% | 131.75% |
| 2019 | 6.35% | -29.64% |
| 2018 | 9.02% | -8.99% |
| 2017 | 9.91% | -35.8% |
| 2016 | 15.44% | 24.32% |
| 2015 | 12.42% | 160.13% |
| 2014 | 4.77% | -62.42% |
| 2013 | 12.71% | -53.95% |
| 2012 | 27.59% | -25.06% |
| 2011 | 36.82% | 11.58% |
| 2010 | 32.99% | 0.15% |
| 2009 | 32.94% | 19.92% |
| 2008 | 27.47% | 1.72% |
| 2007 | 27.01% | -16.3% |
| 2006 | 32.27% | 15.92% |
| 2005 | 27.84% | 23.13% |
| 2004 | 22.61% | 1.41% |
| 2003 | 22.29% | -1.48% |
| 2002 | 22.63% | -8.55% |
| 2001 | 24.74% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 306.39% | 🇺🇸 USA |
 Novartis NVS | 17.27% | 206.75% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 514.74% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | 177.09% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | 338.01% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | 223.45% | 🇫🇷 France |
 Biogen BIIB | 31.30% | 455.95% | 🇺🇸 USA |
 Merck MRK | 27.73% | 392.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | 241.74% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | 300.36% | 🇬🇧 UK |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.